Tolerability and effectiveness of (S)-amlodipine compared with racemic amlodipine in hypertension: A systematic review and meta-analysis

Current Therapeutic Research - Clinical and Experimental

Volumn 71, Issue 1, 2010, Pages 1-29

  Liu, Fang ^a   Qiu, Meng ^a   Zhai, Suo Di ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

(S) amlodipine; hypertension; systematic review

Indexed keywords

EID: 80054753652     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.curtheres.2010.02.005     Document Type: Review

References (27)

1. Levine, CB, Fahrbach, KR, Frame, D, et al. Effect of amlodipine on systolic blood pressure. Clin Ther. 25 (2003), 35–57.
2. Pedrinelli, R, Dell'Omo, G, Mariani, M, Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension. J Hum Hypertens 15 (2001), 455–461.
3. Patil, PA, Kothekar, MA, Development of safer molecules through chirality. Indian J Med Sci. 60 (2006), 427–437.
4. Jadad, AR, Moore, RA, Carroll, D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials. 17 (1996), 1–12.
5. Liu, GS, Wang, K, Zhang, MH, Comparative effect of amlodipine and levamlodipine on nocturnal hypertension in hypertensive patients. J Med Postgrad. 14 (2001), 496–499.
6. Cheng, YZ, Wu, XG, Chen, XY, Clinical trial of therapeutic effects and adverse drug reaction of S-amlodipine. Chin J Med Guide. 4 (2002), 198–200.
7. Fang, ZG, Clinical evaluation of levo-amlodipine in treatment of 140 patients with essential hypertension. Chin J New Drugs. 11 (2002), 958–960.
8. Hu, DY, Zhao, XL, Sun, NL, et al. Effects of S-amlodipine and amlodipine in the treatment of primary hypertension: A randomized, double-blind, parallel study. Chin Med. 37 (2002), 46–47.
9. Zeng, H, Tang, H, Gong, CF, Observation of S-amlodipine in the treatment of light to moderate hypertension in elderly patient. Chin J Gerontol. 22 (2002), 484–485.
10. Zhang, H, Liu, KS, Gao, RG, et al. Effects of l-amlodipine and amlodipine on vascular endothelial function and serum cholesterol in patients with essential hypertension. Chin J New Drugs Clin Rem. 22 (2003), 337–340.
11. Fang, ZG, Feng, XJ, S-amlodipine in the treatment of hypertension and angina. Prevent Treat Cardio-Cerebral-Vasc Dis., 4, 2004, 27.
12. Yang, Q, Clinical observation of amlodipine besylate in treating 1 grade/2 grade hypertension [in Japanese]. Ningxia Med J. 26 (2004), 353–354.
13. Pathak, L, Hiremath, PG, Kerkar, Manade, VG, Multicentric, clinical trial of S-amlodipine 2.5 mg versus amlodipine 5 mg in the treatment of mild to moderate hypertension—a randomized, double-blind clinical trial. J Assoc Physicians India. 52 (2004), 197–202.
14. Li, Q, Clinical trial of S-amlodipine in the treatment of mild to moderate hypertension. Chin J Hemorh., 16, 2006, 381.
15. Yang, S, Wang, LQ, Feng, L, et al. Effects of S-amlodipine in mild to moderate hypertension in elderly patients. Clin Focus., 21, 2006, 1269.
16. Zhang, LP, Study of action and adverse drug reaction of levamlodipine besylate and amlodipine besylate. Chin J Pharmacoepidemiol. 15 (2006), 324–325.
17. Gao, JJ, Zhou, JS, Effect of levamlodipine on reducing left ventricular hypertrophy and intimamedia thickness of carotid artery in essential hypertension. Chin Med Factory Mine. 20 (2007), 204–205.
18. Kim, SA, Park, S, Chung, N, et al. Efficacy and safety profiles of a new S(−)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial. Clin Ther. 30 (2008), 845–857.
19. Zhu, Y, Zhu, H, Shi, KL, et al. Effect and safety of levoamlodipine maleate tablets on patients with mild-to-moderate hypertension. Chin J Clin Pharm. 17 (2008), 82–84.
20. Wang, RX, Jiang, WP, Li, XR, Lai, LH, Effects of (S)-amlodipine and (R)-amlodipine on L-type calcium channel current of rat ventricular myocytes and cytosolic calcium of aortic smooth muscle cells. Pharmazie. 63 (2008), 470–474.
21. Messerli, FH, Vasodilatory edema: A common side effect of antihypertensive therapy. Curr Cardiol Rep. 4 (2002), 479–482.
22. Sokol, MC, McGuigan, KA, Verbrugge, RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 43 (2005), 521–530.
23. Mino-León, D, Reyes-Morales, H, Galván-Plata, ME, et al. Drug treatment of hypertension: Compliance and adverse reactions in a cohort of hypertensive patients in a primary care setting. Rev Invest Clin. 59 (2007), 8–14.
24. Berkels, R, Taubert, D, Bartels, H, et al. Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 70 (2004), 39–45.
25. Zhang, XP, Loke, KE, Mital, S, et al. Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine. J Cardiovasc Pharmacol. 39 (2002), 208–214.
26. Park, JY, Kim, KA, Park, PW, et al. Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: A randomized, open-label, two-period, comparative, crossover study. Clin Ther. 28 (2006), 1837–1847.
27. Luksa, J, Josic, D, Kremser, M, et al. Pharmacokinetic behavior of R-(+)- and S-(−)-amlodipine after single enantiomer administration. J Chromatogr B Biomed Sci Appl. 703 (1997), 185–193.